IndraLab
Statements
reach
"Among others, tranilast, an analog of a tryptophan metabolite, was proven to inhibit the activation of the NLRP3 inflammasome in vivo and efficiently suppressed IL-1β production and neutrophil influx after tissue exposure to MSU; it also reduced acute joint swelling in murine models [24]."
reach
"Whole genome sequencing is becoming more accessible and should be useful for providing patient-specific treatment especially if combined with individual organoids.Unlike many ocular surface inflammatory conditions, there are few published studies investigating the role of inflammasomes in ocular allergy, particularly SAC and PAC, despite data showing that Tranilast, used for the treatment of allergic conjunctivitis, directly inhibits NLRP3 [76]."
reach
"In vivo, BHB or a ketogenic diet attenuated caspase-1 activation and IL-1β secretion in mouse models of diseases mediated by NLRP3.Thus, the NLRP3 inflammasome may be a potential target for the treatment of COVID-19 [191,194], which is strongly supported by studies showing improved saturation, reduced hospitalization time and reduced mortality in patients with COVID-19 after treatment with NLRP3 inflammasome inhibitors such as Tranilast [200] or colchicine [198]."
reach
"When BMDMs were stimulated with TR for 30min after 3-h LPS treatment, TR had no effect on LPS induced NLRP3, pro-IL-1beta expression, TNF-alpha, or IL-6 production (Fig XREF_FIG C and D, and XREF_SUPPLEMENTARY), suggesting that TR induced NLRP3 inflammasome inhibition was not caused by the downregulation of NLRP3 or pro-IL-1beta expression at this condition."
reach
"Like the three specific inhibitors mentioned above, Tranilast does not interfere with the upstream signaling pathways of NLRP3 inflammasome, including NLRP3 and pro-IL-1beta expression, K + efflux, mitochondrial damage, ROS production, and chloride efflux, and can not prevent the newly identified NLRP3 inflammasome component NEK7 from interacting with NLRP3 109."
reach
"Moreover, several inhibitors, including parthenolide, Bay 11-7082, INF39, 3,4-methylenedioxy-beta-nitrostyrene, and CY-09, have been reported to inhibit NLRP3 inflammasome activation by suppressing the ATPase activity of NLRP3 (Juliana etal, 2010; He etal, 2014; Cocco etal, 2017; Jiang etal, 2017), so it is possible that TR might inhibit the ATPase activity of NLRP3 to block its oligomerization."